We are live on
!
Find out more
SGH
Sivik Global Healthcare Portfolio holdings
AUM
$132M
1-Year Est. Return
24.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.6%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$220M
AUM Growth
+$21.9M
(+11%)
Cap. Flow
+$60M
Cap. Flow
% of AUM
27.25%
Top 10 Holdings %
Top 10 Hldgs %
29.91%
Holding
89
New
19
Increased
34
Reduced
13
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$3.92M |
| 2 |
Intuitive Surgical
ISRG
|
+$3.35M |
| 3 |
Stryker
SYK
|
+$3.29M |
| 4 |
ResMed
RMD
|
+$2.29M |
| 5 |
Universal Health Services
UHS
|
+$2.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$4.71M |
| 2 |
Viatris
VTRS
|
+$3.87M |
| 3 |
Elevance Health
ELV
|
+$2.87M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$2.66M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
+$2.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.08% |
| 2 | Energy | 0.53% |
| 3 | Industrials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CALL
HCA Healthcare
HCA
$89.1B
| – | – |
-50,500
| Closed | -$187K |
|
77
Pediatrix Medical
MD
$2.12B
| – | – |
-26,100
| Closed | -$1.52M |
|
78
Perrigo
PRGO
$1.78B
| – | – |
-10,000
| Closed | -$1.46M |
|
79
PUT
Vertex Pharmaceuticals
VRTX
$134B
| – | – |
-20,000
| Closed | -$2K |
|
|
80
Viatris
VTRS
$18.7B
| – | – |
-75,000
| Closed | -$3.87M |
|
|
IPXL
81
DELISTED
Impax Laboratories, Inc.
IPXL
| – | – |
-50,000
| Closed | -$1.5M |
|
|
STJ
82
DELISTED
St Jude Medical
STJ
| – | – |
-30,000
| Closed | -$2.08M |
|
|
HTWR
83
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| – | – |
-13,000
| Closed | -$1.15M |
|
|
CFN
84
DELISTED
CAREFUSION CORPORATION
CFN
| – | – |
-60,000
| Closed | -$2.66M |
|
|
NPSP
85
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| – | – |
-40,000
| Closed | -$1.32M |
|
|
ITMN
86
DELISTED
INTERMUNE INC
ITMN
| – | – |
-20,000
| Closed | -$883K |
|
|
FRX
87
DELISTED
FOREST LABORATORIES INC
FRX
| – | – |
-26,100
| Closed | -$2.58M |
|
|
SHPG
88
DELISTED
Shire pic
SHPG
| – | – |
-20,000
| Closed | -$4.71M |
|
|
QGENF
89
DELISTED
QIAGEN NV
QGENF
| – | – |
-49,451
| Closed | -$1.21M |
|
Similar funds
AFP
TCPW
PCGDR
ACM
9C
STFP
ADEF
AC
Sivik Global Healthcare's Q3 2014 Portfolio in Review
As of Q3 2014, Sivik Global Healthcare held 89 positions worth $220M, up 11% from $198M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Sivik Global Healthcare deployed $60M of net new capital in Q3 2014, opening 19 new positions and adding to 34 existing holdings. Its largest new stake was Amgen: 30,000 shares worth $4.21M.
By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 88% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was Elevance Health, an estimated $2.87M trimmed.
- Sivik Global Healthcare's largest Q3 2014 buy was Amgen: 30,000 shares worth $4.21M.
- Sivik Global Healthcare added most to Universal Health Services in Q3 2014, an estimated $2.12M increase.
- Sivik Global Healthcare's biggest Q3 2014 reduction was Elevance Health, cutting an estimated $2.87M.
- Sivik Global Healthcare fully exited Shire pic in Q3 2014, selling an estimated $4.71M.
- Sivik Global Healthcare's ten largest holdings make up 30% of its $220M portfolio in Q3 2014.
- Sivik Global Healthcare opened 19 new positions and closed 20 in Q3 2014.
- Sivik Global Healthcare's portfolio value rose 11% quarter-over-quarter to $220M.
Based on Sivik Global Healthcare's 13F filing for Q3 2014, filed 3 Oct 2014.